← Back to Search

Antihistamine

Mast Cells in Male Pelvic Pain and and Lower Urinary Tract Dysfunction

Phase < 1
Waitlist Available
Led By Praveen Thumbikat, PhD
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 weeks
Awards & highlights
Approved for 10 Other Conditions
All Individual Drugs Already Approved
No Placebo-Only Group

Summary

This trial tests two medications, Cromolyn Sodium and Cetirizine, to help men with chronic prostatitis and chronic pelvic pain syndrome. These medications aim to reduce pain and swelling by stopping certain immune cells from releasing harmful chemicals. The study will measure changes in symptoms and specific chemical levels in the body over time.

Eligible Conditions
  • Chronic Prostatitis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Mast cell tryptase levels in expressed prostatic secretions
Secondary study objectives
AUA-SI score
NIH-CPSI score

Awards & Highlights

Approved for 10 Other Conditions
This treatment demonstrated efficacy for 10 other conditions.
All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Treatment armExperimental Treatment2 Interventions
Treated arm with cromolyn sodium and cetirizine hydrochloride
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cromoglicic acid
FDA approved
Cetirizine
FDA approved

Find a Location

Who is running the clinical trial?

Northwestern UniversityLead Sponsor
1,649 Previous Clinical Trials
958,751 Total Patients Enrolled
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,455 Previous Clinical Trials
4,335,088 Total Patients Enrolled
Praveen Thumbikat, PhDPrincipal Investigator - Northwestern University
Northwestern University
2 Previous Clinical Trials
197 Total Patients Enrolled
~2 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top